The cutaneous analgesic effect of class I antiarrhythmic drugs

被引:14
作者
Tzeng, Jann-Inn
Cheng, Kuang-I
Huang, Kuo-Lun
Chen, Yu-Wen
Chu, Koung-Shing
Chu, Chin-Chen
Wang, Jhi-Joung [1 ]
机构
[1] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan
[2] Taipei Med Univ, Dept Anesthesiol, Taipei, Taiwan
[3] Kaohsiung Med Univ, Dept Anesthesiol, Chun Ho Mem Hosp, Kaohsiung, Taiwan
关键词
D O I
10.1213/01.ane.0000256882.13617.ad
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: Local anesthetics, when applied to nerves, produce reversible loss of sensation by blocking Na+ channels. Because all Class I antiarrhythmic drugs are Na+ channel blockers, theoretically, they may have local anesthetic effects. In this study, we sought to define the cutaneous local anesthetic actions of three Class I antiarrhythmic drugs. METHODS: Using a subcutaneous infiltration model in rats, the potencies and durations of action of quinidine (Class IA), mexiletine (IB), and flecamide (IC) were determined and compared with the actions of lidocaine and bupivacaine. Saline injection was used as control. RESULTS: Three Class I antiarrhythmic drugs produced a dose-related cutaneous analgesia with ranking of potencies of bupivacaine > flecainide > quinidine > mexiletine > lidocaine (P < 0.05 for the differences among drugs). On an equipotent basis, the ranking of durations of action was flecainide > quinidine and bupivacaine > mexiletine and lidocaine (P < 0.05 for the differences among drugs). CONCLUSION: Three Class I antiarrhythmic drugs, quinidine (IA), mexiletine (IB), and flecainide (IC) have a local anesthetic effect on cutaneous analgesia.
引用
收藏
页码:955 / 958
页数:4
相关论文
共 17 条
[1]  
Campbell TJ, 2001, BRIT J CLIN PHARMACO, V52, p21S
[2]   International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels [J].
Catterall, WA ;
Goldin, AL ;
Waxman, SG .
PHARMACOLOGICAL REVIEWS, 2005, 57 (04) :397-409
[3]   A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain [J].
Erichsen, HK ;
Hao, JX ;
Xu, XJ ;
Blackburn-Munro, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 458 (03) :275-282
[4]   Mechanism of local anesthetic drug action on voltage-gated sodium channels [J].
Fozzard, HA ;
Lee, PJ ;
Lipkind, GM .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (21) :2671-2686
[5]  
Funao T, 2003, CAN J ANAESTH, V50, P805, DOI 10.1007/BF03019376
[6]   The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury [J].
Hewitt, KE ;
Stys, PK ;
Lesiuk, HJ .
BRAIN RESEARCH, 2001, 898 (02) :281-287
[7]   Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats [J].
Ichimata, M ;
Kitano, T ;
Ikebe, H ;
Iwasaka, H ;
Noguchi, T .
NEUROREPORT, 2001, 12 (09) :1869-1873
[8]   Use of a charged lidocaine derivative, tonicaine, for prolonged infiltration anesthesia [J].
Khan, MA ;
Gerner, P ;
Sudoh, Y ;
Wang, GK .
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2002, 27 (02) :173-179
[9]   Amitriptyline for prolonged cutaneous analgesia in the rat [J].
Khan, MA ;
Gerner, P ;
Wang, GK .
ANESTHESIOLOGY, 2002, 96 (01) :109-116
[10]   Classification and pharmacology of antiarrhythmic drugs [J].
Kowey, PR ;
Marinchak, RA ;
Rials, SJ ;
Bharucha, DB .
AMERICAN HEART JOURNAL, 2000, 140 (01) :12-20